These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 168052)

  • 1. [Serum lipid-lowering drugs following myocardial infarction].
    Schettler G
    Dtsch Med Wochenschr; 1975 Aug; 100(31):1611-2. PubMed ID: 168052
    [No Abstract]   [Full Text] [Related]  

  • 2. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 3. Dextrothyroxine for lowering cholesterol.
    Med Lett Drugs Ther; 1976 Jun; 18(13):53. PubMed ID: 934018
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443
    [No Abstract]   [Full Text] [Related]  

  • 5. The Coronary Drug Project: implications for clinical care.
    Wenger NK; Stamler J
    Prim Care; 1977 Jun; 4(2):247-53. PubMed ID: 195293
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid-lowering drugs. Therapeutics and adverse effects].
    Vogelberg KH
    Med Klin; 1979 Aug; 74(32-33):1171-8. PubMed ID: 224293
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Lipid-lowering drugs after myocardial infarction.
    Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF
    Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
    Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatment of hyperlipidemia.
    Berkowitz D
    Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637
    [No Abstract]   [Full Text] [Related]  

  • 11. [New drug combination for medical management of hyperlipemia: clinical study].
    Fischer M; Falkensammer C
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H; Kolenda KD
    Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
    Mertz DP
    Fortschr Med; 1979 Apr; 97(15):695-6, 698. PubMed ID: 456970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W; Schultz A
    Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of hypolipidemic drugs on serum lipoproteins.
    Carlson LA; Olsson AG
    Prog Biochem Pharmacol; 1979; 15():238-57. PubMed ID: 224397
    [No Abstract]   [Full Text] [Related]  

  • 16. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

  • 17. [Undesirable effects of hypolipemic drugs].
    Schettler G
    Clin Ter; 1980 Mar; 92(5):457-67. PubMed ID: 7449323
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of lipid lowering drugs after myocardial infarction: results of the coronary drug project 1975 (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(37):1167-8. PubMed ID: 1219703
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A; Buzzelli G; D'Alessandro A
    Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
    [No Abstract]   [Full Text] [Related]  

  • 20. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.